COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

30,901 Articles (22,568 medRxiv, 8,333 bioRxiv)

Most recent first Previous |  Page 221: Articles 2201-2210  | Next

Thrombotic and thromboembolic events, with or without thrombocytopenia, following viral vector-based COVID-19 vaccines administration: a systematic review protocol.
Ramos-Rojas, J., Pena, J., Pinto-Diaz, C., Veloso, V., Rada, G., Molina-Leon, H. F.
10.1101/2024.02.22.24303207 — Posted: 2024-02-23
Protection of natural infection against reinfection with SARS-CoV-2 JN.1 variant
Chemaitelly, H., Coyle, P., Kacem, M. A. B., Ayoub, H., Tang, P., Hasan, M. R., YASSINE, H. M., Althani, A., Al-Kanaani, Z., Al-Kuwari, E., Jeremijenko, A., Kaleeckal, A. H., Latif, A. N., Shaik, R. M., Abdul-Rahim, H. F., Nasrallah, G., Al-Kuwari, M. G., Butt, A. A., Al-Romaihi, H. E., Al-Thani, M. H., Al-Khal, A., Bertollini, R., Abu-Raddad, L. J.
10.1101/2024.02.22.24303193 — Posted: 2024-02-23
Modeling the relative influence of socio-demographic variables on post-acute COVID-19 quality of life: an application to settings in Europe, Asia, Africa, and South America
Menkir, T. F., Citarella, B., Sigfrid, L., Doshi, Y., Reyes, L. F., Calvache, J. A., Kildal, A. B., Nygaard, A. B., Holter, J. C., Panda, P. K., Jassat, W., Merson, L., Donnelly, C. A., Santillana, M., Buckee, C., Verguet, S., Hejazi, N. S.
10.1101/2024.02.21.24303099 — Posted: 2024-02-23
Early, robust mucosal secretory IgA but not IgG response to SARS-CoV-2 spike in oral fluid is associated with faster viral clearance and COVID-19 symptom resolution
Pisanic, N., Antar, A. A., Hetrich, M. K., Demko, Z. O., Zhang, X., Spicer, K., Kruczynski, K. L., Detrich, B., Knoll, M. D., Thomas, D. L., Dawood, F. S., Veguilla, V., Karron, R. A., Manabe, Y. C., Heaney, C. D.
10.1101/2024.02.21.24303146 — Posted: 2024-02-23
A specific phosphorylation-dependent conformational switch of SARS-CoV-2 nucleoprotein inhibits RNA binding
Botova, M., Camacho-Zarco, A. R., Tognetti, J., Bessa, L. M., Guseva, S., Mikkola, E., Salvi, N., Maurin, D., Herrmann, T., Blackledge, M.
10.1101/2024.02.22.579423 — Posted: 2024-02-23
Thymidine Phosphorylase Mediates SARS-CoV-2 Spike Protein Enhanced Thrombosis in K18-hACE2TG Mice
Roytenberg, R., Yue, H., DeHart, A., Kim, E., Bai, F., Kim, Y., Denning, K., Kwei, A., Zhang, Q., Liu, J., Zheng, L., Li, W.
10.1101/2024.02.23.581661 — Posted: 2024-02-23
Rates of Positive M-CHAT-R Screenings by Pandemic Birth and Prenatal SARS-CoV-2 Exposure
Firestein, M., Gigliotti Manessis, A., Warmingham, J. M., Hu, Y., Finkel, M. A., Kyle, M. H., Hussain, M., Ahmed, I., Lavallee, A., Solis, A., Chaves, V., Rodriguez, C., Goldman, S., Muhle, R. A., Lee, S., Austin, J., Silver, W. G., O'Reilly, K. C., Bain, J. M., Penn, A. A., Veenstra-VanderWeele, J., Stockwell, M. S., Fifer, W. P., Marsh, R., Monk, C. E., Shuffrey, L. C., Dumitriu, D.
10.1101/2024.02.20.24302892 — Posted: 2024-02-22
Correlates of nucleocapsid antibodies and a combination of spike and nucleocapsid antibodies against protection of SARS-CoV-2 infection during Omicron XBB.1.16 and EG.5 predominant wave
Yamamoto, S., Oshiro, Y., Natsumi, I., Nemoto, T., Tan, T., Horii, K., Okudera, K., Konishi, M., Mizoue, T., Sugiyama, H., Aoyanagi, N., Sugiura, W., Ohmagari, N.
10.1101/2024.02.21.24303122 — Posted: 2024-02-22
Clot Twist - D-dimer analysis of healthy adults receiving heterologous or homologous booster COVID-19 vaccine after a single prime dose of Ad26.COV2.S in a phase II randomised open-label trial, BaSiS.
Patel, F., Le Roux, J., Sawry, S., Kieser, R., Dhar, M., Gill, K., Lazarus, E. M., Nana, A., Garrett, N., Moore, P. L., Sigal, A., Gray, G., Rees, H. V., Jacobson, B., Fairlie, L.
10.1101/2024.02.19.24303026 — Posted: 2024-02-21
The safety of antivirals and neutralising monoclonal antibodies used in prehospital treatment of Covid-19
Bechman, K., Green, A., Russell, M. D., Yang, Z., Zheng, B., Norton, S., Smith, R., Mehrkar, A., Bacon, S., Goldacre, B., MacKenna, B., Galloway, J.
10.1101/2024.02.19.24303044 — Posted: 2024-02-20

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).